High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors

被引:17
作者
Gultekin, Melis [1 ]
Ozyar, Enis [1 ]
Cengiz, Mustafa [1 ]
Ozyigit, Gokhan [1 ]
Hayran, Mutlu [2 ]
Hosal, Sefik [3 ]
Akyol, Fadil [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Prevent Oncol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Ear Nose & Throat Surg, TR-06100 Ankara, Turkey
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2012年 / 34卷 / 07期
关键词
larynx; early glottic carcinoma; radiotherapy; prognostic factors; SQUAMOUS-CELL CARCINOMA; LOCAL-CONTROL; RADIATION-THERAPY; TREATMENT TIME; LARYNX; CANCER; SIZE; COMPLICATIONS; IMPACT;
D O I
10.1002/hed.21860
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background The purpose of this study was to investigate the prognostic factors and treatment results of T1N0M0 glottic laryngeal carcinoma irradiated with 2.3 Gray (Gy) per fraction. Methods A total of 183 patients with glottic carcinoma treated between June 1998 and January 2007 were retrospectively evaluated. Of the 183 patients, 163 patients (89%) had T1a and 20 patients (11%) had T1b disease. All patients received 2.3 Gy per fraction to a median total dose of 64.4 Gy. Results The median follow-up was 63 months. The 5-year overall survival (OS), local control, and cancer-specific survival rates were 89%, 81%, and 90%, respectively. Multivariate analysis showed overall treatment time and age to be significant prognostic factors for local control and OS. We observed no grade IV or grade V acute toxicity. Tracheaesophageal fistula as late toxicity was observed in only 1 patient. Conclusions High daily fraction scheme seems to be a feasible schedule for early glottic carcinomas. (c) 2011 Wiley Periodicals, Inc. Head Neck, 2012
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 28 条
[1]  
[Anonymous], MAN STAG CANC
[2]   Definitive radiotherapy for early glottic carcinoma: Prognostic factors and implications for treatment [J].
Burke, LS ;
Greven, KM ;
McGuirt, WT ;
Case, D ;
Hoen, HM ;
Raben, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (01) :37-42
[3]   Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease [J].
Cellai, E ;
Frata, P ;
Magrini, SM ;
Paiar, F ;
Barca, R ;
Fondelli, S ;
Polli, C ;
Livi, L ;
Bonetti, B ;
Vitali, E ;
De Stefani, A ;
Buglione, M ;
Biti, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05) :1378-1386
[4]  
Chatani Masashi, 1993, Strahlentherapie und Onkologie, V169, P102
[5]   Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? [J].
Fein, DA ;
Lee, WR ;
Hanlon, AL ;
Ridge, JA ;
Curran, WJ ;
Coia, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (04) :823-831
[6]   What is the treatment of choice for Tl squamous cell carcinoma of the larynx? [J].
Ferlito, A ;
Bradley, PJ ;
Rinaldo, A .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2004, 118 (10) :747-749
[7]  
Fletcher G.H., 1980, TXB RADIOTHERAPY, V3rd
[8]   RADIOTHERAPY OF EARLY GLOTTIC CANCER .1. [J].
HARWOOD, AR ;
HAWKINS, NV ;
RIDER, WD ;
BRYCE, DP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (04) :473-476
[9]   HYPERPLASIA, KERATOSIS, DYSPLASIA AND CARCINOMA INSITU OF THE VOCAL CORDS - A FOLLOW-UP-STUDY [J].
HELLQUIST, H ;
LUNDGREN, J ;
OLOFSSON, J .
CLINICAL OTOLARYNGOLOGY, 1982, 7 (01) :11-27
[10]  
KOK G, 1971, RADIOL CLIN, V40, P100